臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

Jump to a point in the index:
Or type in a year:

Show Most Recent First

Ordering With Oldest First

Showing items 2233481-2233505 of 2346973 (93879 Page(s) Totally)
<< < 89335 89336 89337 89338 89339 89340 89341 89342 89343 89344 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-08-31T05:35:47Z	The impact of appointment-based CEO connectedness on firms’ performance and profitability	Chien Y.-H;Hung M.-W.; Chien Y.-H; Hung M.-W.; MAO-WEI HUNG
臺大學術典藏	2021-08-31T05:35:47Z	Implications of default information leakage on recoveries	Hung M.-W;Tsai W.-H.; Hung M.-W; Tsai W.-H.; MAO-WEI HUNG
臺大學術典藏	2021-08-31T05:35:47Z	Consumption-based asset pricing with prospect theory and habit formation	Wang J.-Y;Hung M.-W.; Wang J.-Y; Hung M.-W.; MAO-WEI HUNG
臺大學術典藏	2021-08-31T05:35:47Z	Application of intertemporal CAPM on international corporate finance	Chang J.-R;Hung M.-W;Lee C.F.; Chang J.-R; Hung M.-W; Lee C.F.; MAO-WEI HUNG
臺大學術典藏	2021-08-31T05:35:48Z	Forward osmosis membrane processes for wastewater bioremediation: Research needs	Lee D.-J;Hsieh M.-H.; Lee D.-J; Hsieh M.-H.; MING-HUEI HSIEH
臺大學術典藏	2021-08-31T05:35:48Z	Risk analysis of reservoir sedimentation under non-stationary flows	Tsai C.W;Yeh T.-G;Hsu Y;Wu K.-T;Liu W.-J.; Tsai C.W; Yeh T.-G; Hsu Y; Wu K.-T; Liu W.-J.; YAO-WEN HSU
臺大學術典藏	2021-08-31T05:35:48Z	A population-based study of the influence of socioeconomic status on prostate cancer diagnosis in Taiwan	Wu C.-C;Lin C.-H;Chiang H.-S;Tang M.-J.; Wu C.-C; Lin C.-H; Chiang H.-S; Tang M.-J.; MING JE TANG
臺大學術典藏	2021-08-31T05:44:40Z	Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium–intracellulare complex subspecies and antimicrobial susceptibility	Chang C.-L.; LUN-CHE CHEN; Yu C.-J.; Hsueh P.-R.; Chien J.-Y.
臺大學術典藏	2021-08-31T05:44:40Z	Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study	Lee M.-R.; Huang H.-L.; LUN-CHE CHEN; Yang H.-C.; Ko J.-C.; Cheng M.-H.; Chong I.-W.; Lee L.-N.; Wang J.-Y.; Dimopoulos G.
臺大學術典藏	2021-08-31T05:44:41Z	A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non-small-cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor	LUN-CHE CHEN; Shih J.-Y.; Yu C.-J.; Yang C.-Y.
臺大學術典藏	2021-08-31T05:44:41Z	Clinical features and treatment outcomes of Mycobacterium chimaera lung disease and antimicrobial susceptibility of the mycobacterial isolates	LUN-CHE CHEN; Huang H.-N.; Yu C.-J.; Chien J.-Y.; Hsueh P.-R.
臺大學術典藏	2021-08-31T06:06:17Z	Impacts of treatments on recurrence and 28-year survival of ischemic stroke patients	Wang, Ting-Ann; TZY-HAW WU; Pan, Shin-Liang; Chen, Hsiu-Hsi; Chiu, Sherry Yueh-Hsia
臺大學術典藏	2021-08-31T06:29:13Z	Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression	Ryoo B.-Y.; ANN-LII CHENG; Ren Z.; Kim T.-Y.; Pan H.; Rau K.-M.; Choi H.J.; Park J.-W.; Kim J.H.; Yen C.J.; Lim H.Y.; Zhou D.; Straub J.; Scheele J.; Berghoff K.; Qin S.
臺大學術典藏	2021-08-31T06:29:13Z	Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYnote-240	Ryoo B.-Y.; Merle P.; Kulkarni A.S.; ANN-LII CHENG; Bouattour M.; Lim H.Y.; Breder V.; Edeline J.; Chao Y.; Ogasawara S.; Yau T.; Garrido M.; Chan S.L.; Daniele B.; Norquist J.M.; Chen E.; Siegel A.B.; Zhu A.X.; Finn R.S.; Kudo M.
臺大學術典藏	2021-08-31T06:29:13Z	Pursuing efficacious systemic therapy for hepatocellular carcinoma	ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:13Z	An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular Carcinoma	Shao Y.-Y.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-08-31T06:29:14Z	Noninferiority of cetuximab every-2-weeks versus standard once-weekly administration schedule for the first-line treatment of RAS wild-type metastatic colorectal cancer	Kasper S.; Foch C.; Messinger D.; Esser R.; Lamy F.-X.; Rothe V.; Chen W.; ANN-LII CHENG; Rouyer M.; Brodowicz T.; Zielinski C.
臺大學術典藏	2021-08-31T06:29:14Z	Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma	Sangro B.; Melero I.; Wadhawan S.; Finn R.S.; Abou-Alfa G.K.; ANN-LII CHENG; Yau T.; Furuse J.; Park J.-W.; Boyd Z.; Tang H.T.; Shen Y.; Tschaika M.; Neely J.; El-Khoueiry A.
臺大學術典藏	2021-08-31T06:29:14Z	Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma	Kelley R.K.; Meyer T.; Rimassa L.; Merle P.; Park J.-W.; Yau T.; Chan S.L.; Blanc J.-F.; Tam V.C.; Tran A.; Dadduzio V.; Markby D.W.; Kaldate R.; ANN-LII CHENG; El-Khoueiry A.B.; Abou-Alfa G.K.
臺大學術典藏	2021-08-31T06:29:14Z	Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas	Ma W.-L.; Yeh K.-H.; Yao M.; Tang J.-L.; Lin C.-W.; Wang Y.-T.; Yeh Y.-C.; Wang H.-P.; ANN-LII CHENG; Kuo S.-H.
臺大學術典藏	2021-08-31T06:29:15Z	A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women	Tsai M.-S.; Chang S.-H.; Kuo W.-H.; Kuo C.-H.; Li S.-Y.; Wang M.-Y.; Chang D.-Y.; Lu Y.-S.; Huang C.-S.; ANN-LII CHENG; Lin C.-H.; Chen P.-C.
臺大學術典藏	2021-08-31T06:29:15Z	A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy	Lin Z.-Z.; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; ANN-LII CHENG; Lee R.-C.; Chao Y.; Hsu C.
臺大學術典藏	2021-08-31T06:29:15Z	Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. Reply	Finn R.S.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:16Z	Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial	Kelley R.K.; Ryoo B.-Y.; Merle P.; Park J.-W.; Bolondi L.; Chan S.L.; Lim H.Y.; Baron A.D.; Parnis F.; Knox J.; Cattan S.; Yau T.; Lougheed J.C.; Milwee S.; El-Khoueiry A.B.; ANN-LII CHENG; Meyer T.; Abou-Alfa G.K.
臺大學術典藏	2021-08-31T06:29:16Z	Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design	Kelley R.K.; W Oliver J.; Hazra S.; Benzaghou F.; Yau T.; ANN-LII CHENG; Rimassa L.

Showing items 2233481-2233505 of 2346973 (93879 Page(s) Totally)
<< < 89335 89336 89337 89338 89339 89340 89341 89342 89343 89344 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :2854037
	Visitors : 45326088 Online Users : 736 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library